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SUMMARY
Introduction. The purpose of this experiment was to study the influence of the
apitherapy in acrylamide-induced liver disease in rats. The experimental study objectives
were the evaluation of serum protein electrophoresis parameters (albumin, globulin, alpha-1-
globulin, alpha-2 globulin, beta globulin, albumin ratio/globulin), in conditions of chronic
liver damage induced by acrylamide. To reduce the factors that accelerate progress of liver
damage we have administered Apitherapy products.
Materials and methods. Materials: Apiregya Apitherapy products, ApiImunomod,
ApiImunostim. The apitherapy products were purchased from "Stupina LLC”. The animals
were handled under thiopental induced general anesthesia. Determining the level of
investigated parameters, i.e. serum total protein was measured using an automatic analyzer
(Aeroset, Abbott) and commercial kits (Abbott, USA).  A total of 40 Wistar white rats were
used in the study; they were divided evenly into four groups: standard diet control group
(group I), apitherapy and royal jelly control group (group II), acrylamide group (group III),
acrylamide-apitherapy- royal jelly control group (group IV). The animals were kept under
standard light and temperature conditions with access to food and water ad libitum.  The toxic
liver disease in rats was experimentally induced by gastric gavage administration of
acrylamide (in aqueous solution, 50 mg /kg body weight).
Results and discussions. In comparison to the other treated groups, administration of
apidiet and royal jelly (RJ) in experimental animals with acrilamide–induced hepatopathy
(Group IV) produced: i) an increase in total proteins compared to the Control Group [Group
I] (6.150.03 vs. 7.330.01) and a reduced value for this parameter compared to the Group II
(7.330.01 vs. 6.280.33), ii) an increased level of albumin compared to the Control Group
[Group I] (30.140.69 vs. 41.71.34), Group II (40.710.95 vs. 41.71.34), iii) an increase of
albumin/globulin ratio  compared to Group I (0.4320.01 vs. 0.7200.04),  and a maintainig
of this  ration  compared to Group II (0.60.03 vs. 0.7200.04), iiii) a reduction of levels of
globulins compared to the Control Group [Group I] (69.850.69 vs. 58.411.12), with similar
results for globulins as those obtained for Group II (59.141.06 vs. 58.411.12). Regarding
the globulins fractions, we can remarks these are returned to normal values in the animals
with acrilamide–induced hepatopathy and treated with apidiet and royal jelly.
Conclusions. It is recommended to administer apitherapy preparations Apiregya,
ApiImunostim, ApiImunomod for normalizing the parameters of serum protein electrophoresis
in liver damage  induced by toxic food.
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